LexDanaLexDanabeta
Inventor

Ai Ling CHING

Inventor
US

Overview

3→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61BDiagnosis13%
C07DHeterocyclic compounds13%
PatentTitleYear
11,795,180Formulation of a pan-JAK inhibitor202311,684,605Lisinopril compositions with an ingestible event marker202311,471,442Administration of gut-selective JAK3 inhibitor2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to THERAVANCE BIOPHARMA R&D IP LLC (2)· patent assignee history
2022–2023Based in US· patent location history
2023Patents assigned to OTSUKA PHARMA CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
THERAVANCE BIOPHARMA R&D IP LLC22022–2023
OTSUKA PHARMA CO LTD12023
Locations
LocationPatentsSpan
US32022–2023